Visual control of locomotion typically involves both detection of current egomotion as well as anticipation of impending changes in trajectory. To determine if there are distinct neural systems involved in these aspects of steering control we used a slalom paradigm, which required participants to steer around objects in a computer simulated environment using a joystick. In some trials the whole slalom layout was visible (steering "preview" trials) so planning of the trajectory around future waypoints was possible, whereas in other trials the slalom course was only revealed one object at a time (steering "near" trials) so that future planning was restricted. In order to control for any differences in the motor requirements and visual properties between "preview" and "near" trials, we also interleaved control trials which replayed a participants' previous steering trials, with the task being to mimic the observed steering. Behavioral and fMRI results confirmed previous findings of superior parietal lobe (SPL) recruitment during steering trials, with a more extensive parietal and sensorimotor network during steering "preview" compared to steering "near" trials. Correlational analysis of fMRI data with respect to individual behavioral performance revealed that there was increased activation in the SPL in participants who exhibited smoother steering performance. These findings indicate that there is a role for the SPL in encoding path defining targets or obstacles during forward locomotion, which also provides a potential neural underpinning to explain improved steering performance on an individual basis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575057 | PMC |
| http://dx.doi.org/10.3389/fnbeh.2013.00009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stability of small incision lenticule extraction over laser in situ keratomileusis at an altitude of 3874 m.
Sci Rep
January 2025
Xinqiao Hospital, Army Medical University, 183th, Xinqiao Street, Shapingba District, Chongqing, China.
The purpose of this study was to evaluate the stability of small-incision lenticule extraction (SMILE) and laser in situ keratomileusis (LASIK) when ascending from near sea level to an altitude of 3874 m. The visual acuity (VA), intraocular pressure (IOP), spherical equivalent refraction (SER) and biometric parameters of 20 normal subjects (40 eyes, controls) and 36 subjects who underwent corneal refractive surgery (35 eyes with SMILE and 36 eyes with LASIK) were examined in Chongqing (C, 500 m above sea level) and 7-10 days after a collective travel to Shigatse (S, 3874 m above sea level). SER and corneal thickness (CT) were choosed as main indicators of the stability of corneal refractive surgery at high altitude.
View Article and Find Full Text PDFIndocyanine green dyed gauze-guided minimum invasive surgery for anatomical landmarks and preventing gauze remnants: a pilot study.
Langenbecks Arch Surg
January 2025
Department of Chemical Science & Engineering, School of Materials and Chemical Technology, Institute of Science Tokyo, 2-12-1 Ookayama, Meguro-ku, Tokyo, 152-8552, Japan.
Purpose: We aimed to develop a novel fluorescent surgical gauze dyed with indocyanine green (ICG) to guide surgeons to the target anatomical destination during surgery for real-time navigation and to prevent gauze remnants after surgery.
Methods: Surgical gauze was dyed with an aqueous solution of ICG (5.0 × 10 mol L for Steraze, 1.
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study.
J Neurol
January 2025
Division of Child Neurology, Children's Hospital of Philadelphia, Departments of Neurology and Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Background: The presented study identified the appropriate ocrelizumab dosing regimen for patients with pediatric-onset multiple sclerosis (POMS).
Methods: Patients with POMS aged 10-17 years were enrolled into cohort 1 (body weight [BW] < 40 kg, ocrelizumab 300 mg) and cohort 2 (BW ≥ 40 kg, ocrelizumab 600 mg) during a 24-week dose-exploration period (DEP), followed by an optional ocrelizumab (given every 24 weeks) extension period.
Primary Endpoints: pharmacokinetics, pharmacodynamics (CD19 B-cell count); secondary endpoint: safety; exploratory endpoints: MRI activity, protocol-defined relapses, Expanded Disability Status Scale (EDSS) score change.
Improvement in vision-related quality-of-life using the NEI-VFQ-9 over 1-year in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT).
Graefes Arch Clin Exp Ophthalmol
January 2025
Department of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Purpose: To examine the nine-item National Eye Institute Vision Function Questionnaire (NEI-VFQ-9) scores at baseline and 12 months in participants enrolled in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) and determine factors associated with improvements in vision-related quality-of-life (VRQOL).
Methods: Retrospective review of NEI-VFQ-9 scores at baseline and 12-month follow-up in a community-based eye health screening study conducted in Upper Manhattan, New York. Participants were age ≥ 40 years and older, living independently in public/affordable housing developments and able to provide informed consent.
Defecation after magnesium supplementation enhances cognitive performance in triathletes.
Sports Med Health Sci
March 2025
Laboratory of Exercise Biochemistry, University of Taipei, Taipei City, Taiwan, China.
Constipation is correlated with diminished cognitive function, revealing a possible rectum-brain connection. In this counter-balanced crossover trial, 13 elite triathletes underwent a Stroop test to assess cognitive function and executive control. The Stroop test was conducted both with and without magnesium oxide intake, with a 1-week washout period between sessions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!